As of April 2026 Evommune has a market cap of A$1.30 Billion. This makes Evommune the world's 6183th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Apr 10th, 2026 the market cap of Evommune was reported to be: